Zhai; Xiaoting

Patent Applications and Registrations

Patent applications and USPTO patent grants for Zhai; Xiaoting.The latest application filed is for "cabozantinib malate crystal form, preparation method and use thereof".

Company Profile

10.7.12

Zhai; Xiaoting - Suzhou CN
Zhai; Xiaoting - Jiangsu CN

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Cabozantinib Malate Crystal Form, Preparation Method And Use Thereof App 20210332014 - Chen; Minhua ; et al.	2021-10-28
Crystalline form of EB-1020, processes for preparation and use thereof Grant 11,149,004 - Chen , et al. October 19, 2	2021-10-19
Crystalline Forms Of Arn-509, Preparation Method And Use Thereof App 20210300893 - Chen; Minhua ; et al.	2021-09-30
Crystalline Forms Of Ozanimod And Processes For Preparation Thereof App 20210292287 - Chen; Minhua ; et al.	2021-09-23
Crystalline form of ozanimod hydrochloride, and processes for preparation thereof Grant 11,117,876 - Chen , et al. September 14, 2	2021-09-14
Crystalline forms of ozanimod and ozanimod hydrochloride, and processes for preparation thereof Grant 11,111,223 - Chen , et al. September 7, 2	2021-09-07
Crystalline forms of ARN-509, preparation method and use thereof Grant 11,066,384 - Chen , et al. July 20, 2	2021-07-20
Crystalline Form Of Eb-1020, Processes For Preparation And Use Thereof App 20210179558 - Chen; Minhua ; et al.	2021-06-17
Crystalline forms of ozanimod and processes for preparation thereof Grant 11,028,060 - Chen , et al. June 8, 2	2021-06-08
Crystalline Forms Of Arn-509, Preparation Method And Use Thereof App 20210017148 - Chen; Minhua ; et al.	2021-01-21
Crystal form of ozanimod hydrochloride and processes for preparation therefor Grant 10,882,830 - Chen , et al. January 5, 2	2021-01-05
Crystalline Form Of Ozanimod Hydrochloride, And Processes For Preparation Thereof App 20200339524 - Chen; Minhua ; et al.	2020-10-29
Crystalline Forms Of Arn-509, Preparation Method And Use Thereof App 20200270226 - Chen; Minhua ; et al.	2020-08-27
Crystalline forms of a bromodomain and extraterminal protein inhibitor drug, processes for preparation thereof, and use thereof Grant 10,752,595 - Chen , et al. A	2020-08-25
Crystal Forms Of Ozanimod And Preparation Method Therefor App 20200216404 - CHEN; Minhua ; et al.	2020-07-09
Crystalline Forms Of Ozanimod And Ozanimod Hydrochloride, And Processes For Preparation Thereof App 20200157065 - Chen; Minhua ; et al.	2020-05-21
Crystalline Forms Of Ozanimod And Ozanimod Hydrochloride, And Processes For Preparation Thereof App 20190337908 - CHEN; Minhua ; et al.	2019-11-07
Crystalline Forms Of A Bromodomain And Extraterminal Protein Inhibitor Drug, Processes For Preparation Thereof, And Use Thereof App 20190330161 - Chen; Minhua ; et al.	2019-10-31
Crystal Form Of Ozanimod Hydrochloride, And Preparation Method Therefor App 20190248755 - CHEN; Minhua ; et al.	2019-08-15

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.